← back to search

Korinna Jöhrens

University Hospital Carl Gustav Carus · DE
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, and Cancer Genomics and Diagnostics.
h-index
40
citations
5,432
works
218
NIH funding
primary concept
email

Recent publications

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors
Med 2025cited by 9position: middledoi
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP®)
Cancers 2025cited by 1position: middledoi
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy
European Journal of Cancer 2024cited by 21position: middledoi
Molecular subtyping of head and neck cancer – Clinical applicability and correlations with morphological characteristics
Oral Oncology 2024cited by 5position: middledoi
A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patientswith advanced multiple myeloma
Haematologica 2024cited by 1position: middledoi
Testing for deficient mismatch repair and microsatellite instability
Die Pathologie 2023cited by 30position: middledoi
Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy
Frontiers in Immunology 2023cited by 10position: middledoi
Testung auf Mismatch-Reparatur-Defizienz und Mikrosatelliteninstabilität
Die Pathologie 2023cited by 3position: middledoi
Erratum zu: Testung auf Mismatch-Reparatur-Defizienz und Mikrosatelliteninstabilität
Die Pathologie 2023cited by 2position: middledoi
The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts
Radiotherapy and Oncology 2023cited by 1position: middledoi
Abstract 926: Genomics-based personalized oncology of advanced thymic epithelial tumors
Cancer Research 2023cited by 1position: middledoi
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
Journal of Hematology & Oncology 2022cited by 55position: middledoi
The Immune Contexture of Liposarcoma and Its Clinical Implications
Cancers 2022cited by 21position: middledoi
The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases
Anticancer Research 2022cited by 15position: middledoi
Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma
Journal of Cancer Research and Clinical Oncology 2022cited by 13position: middledoi
Treatment options for critical size defects - Comparison of different materials in a calvaria split model in sheep
Biomaterials Advances 2022cited by 7position: middledoi
Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia
Acta Oncologica 2022cited by 5position: middledoi
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
Cancers 2022cited by 5position: middledoi
Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease
Frontiers in Immunology 2022cited by 2position: middledoi
Prevalence, Clinical and Molecular Features, and Prognostic Value of Tetraploidy/Near-Tetraploidy in Patients with Acute Myeloid Leukemia
Blood 2022cited by 1position: middledoi
Routineuntersuchungen der Pathologie für die Therapie mit modernen Medikamenten
best practice onkologie 2022cited by 0position: firstdoi
Prognostic Significance of Estrogen Receptor Alpha in Oral Squamous Cell Carcinoma
Cancers 2021cited by 34position: lastdoi
MSI testing
Der Pathologe 2021cited by 20position: middledoi
Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2021cited by 9position: middledoi
Tomoelastography for Longitudinal Monitoring of Viscoelasticity Changes in the Liver and in Renal Allografts after Direct-Acting Antiviral Treatment in 15 Kidney Transplant Recipients with Chronic HCV Infection
Journal of Clinical Medicine 2021cited by 9position: middledoi
MSI-Testung
Der Pathologe 2021cited by 8position: middledoi
Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL)
Cancers 2021cited by 6position: middledoi
Long-Term Mixed Chimerism After Ex Vivo/In Vivo T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms
Frontiers in Oncology 2021cited by 2position: middledoi
Support of a molecular tumour board by an evidence-based decision management system for precision oncology
European Journal of Cancer 2020cited by 35position: middledoi
Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expression
OncoImmunology 2020cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ulrich Keilholz · German Marine Research Consortium11 papers (2015–2024)Frederick Klauschen · Institute of Clinical Cancer Research11 papers (2016–2023)Manfred Dietel · Charité - Universitätsmedizin Berlin10 papers (2013–2023)Wilko Weichert · German Cancer Research Center10 papers (2015–2024)Michael Hummel · German Cancer Society8 papers (2016–2021)Ingeborg Tinhofer · German Cancer Research Center8 papers (2015–2024)Konrad Klinghammer · Humboldt-Universität zu Berlin7 papers (2015–2024)Albrecht Stenzinger · Chirurgische Universitätsklinik Heidelberg7 papers (2015–2023)Volker Budach · Freie Universität Berlin7 papers (2015–2019)Gustavo Baretton · National Center for Tumor Diseases6 papers (2021–2023)Sabine Merkelbach‐Bruse · University Hospital Cologne6 papers (2021–2023)Max Heiland · Humboldt-Universität zu Berlin6 papers (2017–2022)Inge Tinhofer · German Cancer Research Center6 papers (2016–2019)Damian Rieke · German Cancer Research Center6 papers (2016–2020)Reinhard Büttner · University of Tübingen6 papers (2021–2023) · 6 papers (2021–2023)Jan-Dirk Raguse · Fachklinik Hornheide6 papers (2015–2022)Hans‐Ulrich Schildhaus · University of Kassel6 papers (2021–2025)Wolfgang Dietmaier · University of Regensburg5 papers (2021–2023)David Horst · German Cancer Research Center5 papers (2021–2023)